Abiopharma

🔍 Evans Javier L. (Executive)

Company: WEBSTER FINANCIAL CORP (WBS)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 14,948 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 44,157.32 | transaction_form_type: 4 | Footnotes: F2
• Sold 7,633 shares of Common Stock at $79.07 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 36,524.32 | transaction_form_type: 4 | Footnotes: F3
• Sold 1,054 shares of Common Stock at $79.07 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 35,470.32 | transaction_form_type: 4 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: H | shares_owned_after: 29,209.32 | Footnotes: F1

Footnotes:

• F1: Reflects 71.178 shares purchased through Webster Financial Corporation's Employee Stock Purchase Plan, as amended and restated effective April 1, 2019, since most recent Form 4 filed on March 13, 2026.
• F2: Represents the vesting of certain performance shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.
• F3: Represents the tax withholding upon the vesting of certain performance shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.
• F4: Represents the tax withholding upon the vesting of certain time-based restricted shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.